Side-by-side financials for ADXN and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADXN | NVS |
|---|---|---|
| Market cap | - | $282.64 B |
| US-listed rank | - | #47 |
| SEC filings | 259 | 947 |
Full pages: Addex Therapeutics Ltd. and Novartis AG, or browse the full rankings.